Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

[1]  H. Minn,et al.  Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Christer Halldin,et al.  Methylation of amide and thiol functions with [11C]methyl triflate, as exemplified by [11C]NMSP[11C]flumazenil and [11C]methionine , 1998 .

[3]  M Schwaiger,et al.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. , 1998, International journal of radiation oncology, biology, physics.

[4]  H. Minn,et al.  Dose characteristics of in-house-built collimators for stereotactic radiotherapy with a linear accelerator. , 1998, Physics in medicine and biology.

[5]  A. Thiel,et al.  11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.

[6]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Piérart,et al.  Immediate postoperative radiotherapy in low grade glioma improves progression free survival, but not overall survival: preliminary results of an EORTC/MRC randomized phase III study. , 1998 .

[8]  D. Louis,et al.  Chemosensitive gliomas in adults: which ones and why? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  H. Minn,et al.  Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  P Aaltonen,et al.  Specification of dose delivery in radiation therapy , 1997 .

[12]  P Aaltonen,et al.  Specification of dose delivery in radiation therapy. Recommendation by the Nordic Association of Clinical Physics (NACP). , 1997, Acta oncologica.

[13]  A. Karim,et al.  A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. , 1996, International journal of radiation oncology, biology, physics.

[14]  V. Levin.  Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas. , 1996, Current opinion in oncology.

[15]  K. Någren,et al.  Comparison of [11C]methyl triflate and [11C]methyl iodide in the synthesis of PET radioligands such as [11C]β-CIT and [11C]β-CFT , 1995 .

[16]  K. Någren,et al.  Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate. , 1995, Nuclear medicine and biology.

[17]  M. Berger,et al.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.

[18]  D. Macdonald.  Low-grade gliomas, mixed gliomas, and oligodendrogliomas. , 1994, Seminars in oncology.

[19]  J. Cairncross.  Aggressive oligodendroglioma: a chemosensitive tumor. , 1992, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[20]  I. Kanno,et al.  Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. , 1994, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  R L Wahl,et al.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.

[22]  H. Fine,et al.  Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults , 1993, Cancer.

[23]  F Shishido,et al.  Cerebral glioma: evaluation with methionine PET. , 1993, Radiology.

[24]  F. Shishido,et al.  Clinical value of pet with fluorine 18 fluorodeoxyglucose and l methyl carbon 11 methionine for diagnosis of recurrent brain tumor and radiation injury , 1991 .

[25]  K. Ishiwata,et al.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. , 1991, Journal of Nuclear Medicine.

[26]  F. Shishido,et al.  Clinical Value of Pet with 18F-Fluorodeoxyglucose and L-Methyl-11C-Methionine for Diagnosis of Recurrent Brain Tumor and Radiation Injury , 1991, Acta radiologica.

[27]  M. Mehta,et al.  Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy. , 1991, International journal of radiation oncology, biology, physics.

[28]  A. Syrota,et al.  [11C]L-methionine uptake in gliomas. , 1989, Neurosurgery.

[29]  W. Paulus,et al.  Intratumoral histologic heterogeneity of gliomas. A quantitative study , 1989, Cancer.

[30]  M. Bergström,et al.  Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference , 1989, Acta radiologica.

[31]  Y. Olsson,et al.  Positron Emission Tomography and Computed Tomography in Differential Diagnosis between Recurrent or Residual Glioma and Treatment-Induced Brain Lesions , 1989, Acta radiologica.

[32]  M. Gilardi,et al.  Physical performance of the latest generation of commercial positron scanner , 1988 .

[33]  M. Bergström,et al.  Positron Emission Tomography with 11C-Methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies , 1987, Acta radiologica.

[34]  G. Chiro.  Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .

[35]  M. Bergström,et al.  Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors. , 1985, Journal of computer assisted tomography.

[36]  A. Lilja,et al.  Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography. , 1985, AJNR. American journal of neuroradiology.

[37]  R. Brooks,et al.  Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. , 1983, AJNR. American journal of neuroradiology.

[38]  R A Brooks,et al.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography , 1982, Neurology.

[39]  H. Woodard,et al.  Expression of Tissue Isotope Distribution , 1975 .

[40]  H. Woodard,et al.  Letter: Expression of tissue isotope distribution. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.